





Masterclass: Current State of Routes to Market in Digital Health
Digital health solutions can be commercialized in various ways depending on factors such as value proposition, stakeholders, and regulatory requirements. Join this expert led Masterclass to dive deeper into this topic.







Masterclass: Design and Control Conditions for Clinical Trials of Digital Health Solutions
Clinical efficacy is a crucial factor for the commercial success of Digital Health solutions. Apply now to join HealthXL in this session as we deep dive into this topic.







Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.







Masterclass: Operations Considerations for Designing Clinical Trials for Digital Health Solutions
Conducting RCTs is a significant undertaking that requires substantial investments and financial resources. Apply now to join your peers in this expert led Masterclass.







Data Monetisation for MedTech Companies
With the proliferation of digital health solutions developed and commercialised by MedTech firms, the volume of healthcare data they generate is expanding rapidly. Apply now to join your peers and discuss this topic further.







Panel Discussion: Patient Engagement Through a Digital Health Front Door
The digital front door is a powerful approach to improve patient engagement and care delivery, but it requires a patient-centric and holistic approach to be successful. Apply now to join HealthXL in this panel discussion with leaders working in this space.







Embracing Digital Health for Hospital at Home Solutions
By reducing hospital admissions, and in-person care services, digital hospital at home solutions are emerging as cost-effective services for health systems. Join HealthXL in this discussion. Apply now to secure your place.







Digital Health to Overcome the Siloed Care Pathways in Immunology
Digital health care pathways in immunology can become siloed due to the fragmentation of healthcare services and the lack of interoperability among healthcare systems and providers. Apply now to join this session and deep dive into this topic with your peers working in this space.







Masterclass: Understanding the Burden of Digital Health Compliance: Regulations, Security & Privacy
Are your Digital Health innovations being slowed or even derailed by regulatory, security, privacy or legal compliance considerations? Apply now to join HealthXL in this expert led Masterclass to deep dive into this topic.







Panel Discussion: The Potential of OTC DTx Solutions
Curious about what is in store for the future of OTC DTx solutions? Join in the conversation with our expert panel to find out! Spaces are limited so apply now to secure your place.







Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss the highlights from the report and how pharma can do digital health better in the next few years.






Are Hospitals the Right Partner for Digital Health Companies in Oncology?
Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.







Hybrid Care: How Should the Industry Work Together to Make It Impactful?
Whilst the Covid-19 outbreak created strong incentives to go digital, it also demonstrated the value of in-person interactions. Apply now to join this session and dive deeper into this topic with your peers working in this space.






Masterclass: Making Precision Medicine Accessible and Affordable
One-size-fits-all approach is outdated; every patient is different. Apply now to join this Masterclass led by Jason Foster who will deep dive into this topic.







Masterclass: How Can DTx Companies Enter the US Market Successfully?
Despite the rapid expansion of the digital therapeutics (DTx) market in the US, DTx companies are still facing challenges in establishing a foothold and making an impact in the digital health industry. Join this masterclass with Jonas Duss (Co-Founder at Kaia Health) to discuss the key challenges facing DTx companies seeking to enter the US market. Seats are limited so apply now to secure your place.







Beyond the Provider: Alternative Paths to Adoption of Oncology Digital Health Solutions
Engaging healthcare providers is crucial to drive patient adoption of digital health solutions. Apply now to join HealthXL in this peer to peer discussion.







Masterclass: Accelerating Reimbursement: Strategies for Effective Evidence Planning and Execution
Are you working on developing an evidence-based digital health/digital medicine solution with the goal of obtaining payer reimbursement? Apply now to join this Masterclass led by Todd Greenwood and Craig Buell from the ZS Digital Connected Health Group where they will discuss this topic further.







Partnership Roadmap with Life Sciences Companies for Digital Health in Cardiometabolic Diseases
Life sciences companies and digital health startups are teaming up to improve outcomes and reduce the burden of cardiometabolic diseases. Join HealthXL in this session to deep dive into this topic. Apply now to secure your place.







Masterclass: When and how should your digital health solution be regulated?
Do you need guidance on the best practices for gaining regulatory approval for your digital health solution? Then this masterclass is the perfect fit for you! Apply now to secure your place.







Masterclass: How to Implement Patient-Centric Solutions in digital evidence generation
We all know that it's important to choose "measures that matter" when selecting and developing digital measures for evidence generation in clinical trials, but how do we put these good intentions into action? Join us in this expert led Masterclass to learn more about this topic. Seats are limited so apply now to secure your place.







Masterclass: How to Make Value-Based Health Care (VBHC) work with Digital Health?
Would you like to learn more about value-based health care models (VBHC) and the interplay between these systems and digital health solutions? Join HealthXL in this Masterclass led by Matt Hickey to deep dive into this topic. Seats are limited so apply now to secure your place.







Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 2)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. Apply now to join this 2 part session where you will discuss 5 key challenges and agree on 5 key recommendations around this topic with your peers.







Innovation Showcase: Digital Biomarkers in CNS and Cognition Assessment
In this innovation showcase, 3 Digital Biomarkers companies working on CNS and cognition assessment will meet 121 with 3 Pharma/Medtech/Investors to discuss mutual challenges when building successful collaborations. Seats are limited to 3 Pharma/Medtech/Investors and 3 Digital Biomarkers companies so we can pair you 1-2-1. Apply now to book your place!






Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss how pharma can do digital health better in the next few years.






HealthXL Webinar: Digital Health: Are we at a Turning Point?
Digital health's interaction with pharma is evolving; it has to evolve. In this webinar, we will have a panel discussion with forefront leaders in digital health. Join now to secure your place.







Scalable Market Access Strategies Targeting Payers in the US
Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Apply now to join your peers as we deep dive into this topic.







Patient Engagement Metrics in Digital Health for Oncology
Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. Join this discussion to dive deeper into this topic with your peers working in this space. Seats are limited to apply now to secure your place.







Masterclass: How Germany Channelled Digital Health Apps into its Health System: Navigating the DiGA Framework
Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Apply now to join this Masterclass led by Jonas Albert (Digital Health Expert at fbeta) and Hans-Holger Bleß (Partner at fbeta).







Extended-Reality (XR) Solutions in Mental Health and Substance Use Disorders
Extended Reality (XR) is a powerful technology that can be used anywhere, at any time. Join HealthXL in this meeting as we discuss this topic further. Seats are limited so apply now to secure your place.







Sprint: Beyond Piloting: Growth and Scaling of Pharma-DTx Partnerships (Part 1)
Pharma-DTx Partnerships can be a good strategy when they speak the same language. Apply now to join this 2 part session to address 5 key challenges and agree on 5 key recommendations around this topic.







Masterclass: Leveraging Sources of US Government Funding for Digital Health (beyond NIH and SBIR/STTR)
Industry is from Mars. The Government is from Venus. How can digital health companies get R&D and commercialization US government funding? Apply now to join this Masterclass led by industry leaders.







Beyond Pharma: Finding the Best Commercial Partner for Digital Health in Oncology
Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Seats are limited for this event so apply now to deep dive into this topic with your peers.







Masterclass: Incorporating Extended Reality (XR) in Physicians’ Daily Work
The healthcare industry is undergoing a digital transformation and extended reality (XR) technologies such as virtual reality (VR) and augmented reality (AR) are expected to play a significant role in this change in the next few years. Apply now to join this Masterclass led by Nemanja Kovačev, MedTech Expert at HTEC Group.







Innovation Showcase: Digital Health Solutions in Oncology
In this innovation showcase, 3 Digital Health companies in Oncology will meet 121 with 3 Pharma/Medtech/Investors/Healthcare Providers, to discuss mutual challenges when building successful collaborations. Apply now to join this session as seats are limited.






Standards for Robust Evidence from Digital Health in Oncology
Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.







Digital Biomarkers for Mental Health Evaluation and Management
Unlike other therapeutic areas, mental health evaluation and management can be a bit of an art, and at times relies on subjectivity in the outcomes analysis. Join this meeting to discuss this topic further with others working in this space. Places are limited so apply now to avoid disappointment.







The Role of the Consumer Experience in DTx
As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.







Masterclass: Endpoints and Control Arms in Trials for DTx
Proving clinical efficacy is one of the biggest challenges for DTx companies. Apply now to join HealthXL in this session to dive deeper into this topic with leaders in this field.







Masterclass: Standing Out from the Crowd in Economic Recession
The digital health industry has seen a decline in funding in recent times, as investors have become more knowledgeable and selective to where they allocate their capital. Seats are limited so apply now to secure your place.






Business Opportunities for Digital Health in Autoimmune Conditions: Upcoming Blockbuster Drugs
Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.







Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area
In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better health outcomes and less hospitalizations, emergency visits, and in-office visits.







Masterclass: How to Navigate the NHS Digital Technology Assessment Criteria and NICE evidence guidelines
Are you trying to increase adoption and use of your Digital Health solution across the UK's National Health Service? Join your peers in this meeting as they deep dive into this topic. Apply now to secure your place as seats are limited.







HealthXL Webinar: The Potential of AI in Drug Discovery
The drug discovery process has traditionally been costly and very time-consuming. Join this Webinar to deep dive into this topic with senior leaders in this area.







HealthXL Webinar: Retail Healthcare: Current and Future Opportunities for Digital Health
Are we entering the era of retail health and retail medicine? What role does digital health play in retail healthcare? Join HealthXL in this webinar where we will deep dive into this topic with Adam Pellegrini (former SVP Enterprise Virtual Care & Consumer Health Innovation at CVS, former VP Digital Health at Walgreens, currently CEO at Jasper Health).







Sprint: How Can DTx Companies De-Risk Combination Products for Better Pharma Adoption? (Part 2)
Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your space.







Masterclass: FDA Breakthrough Designation: How Can DTx Companies Navigate it?
Getting regulatory clearance/approval for DTx can be challenging, and it requires a learning curve to define the best regulatory strategy for a specific solution. Join this Masterclass to deep dive into this topic further.







Masterclass: The Use of RWD to Build Economic Evidence for Digital Health Market Access
Digital health companies need to show economic evidence for their solutions, but building that evidence can be very difficult, especially for small companies that are new in the market. Join this meeting to deep dive into this topic with other senior leaders in this field.







Masterclass: How to Move from DTx Point Solutions to Platforms?
Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.







Healthcare Provider Adoption of Digital Solutions in Mental Health
How can we help healthcare providers and health systems sift through the universe of digital solutions in mental health? How can digital health companies engage providers? Join this meeting to deep dive into this topic with your peers. Spaces are limited so apply now to secure your place.







Digital Health for Trigger Management in Autoimmune Conditions
It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.







Increase DTx Market Access and Adoption via Precision Patient Engagement
Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.







How Can Virtual Care Solutions Help Health Systems Bounce Back After Covid?
Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.







Masterclass: Human-Centered Design in Digital Health: Case Studies
In this masterclass, we will touch on different case studies of human-centered design in digital health. Spaces are limited so apply now to secure your seat.







Revenue Generation in Pharma-DTx Partnerships
Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. Apply now to secure your place in this Digital Health meeting.
.jpg)






Sprint: How Can DTx Companies De-Risk Combination Products for Better Pharma Adoption? (Part 1)
Pharma companies are not risk takers, and adding a DTx to their products can be seen as a threat rather than a value-add. In this sprint, we will break this down into 5 key challenges and agree on 5 key recommendations to overcome them. Seats are limited so apply now to secure your place.







Sprint: Pharma Sales Model for DTx-Drug Combination (Part 2)
While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations with your peers working in this space.







The Intersection between DTx and Human Coaching in Mental Health
The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.







Innovation Showcase: Remote Patient Monitoring Programs in Oncology
In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.







Masterclass: DTx Access Negotiation and Contracting with Commercial Health Plans in the US
Are you seeking reimbursement of a DTx solution in the US? Join this Masterclass led by Mike Pace to deep dive into this topic with your peers working in this space.







Innovative Distribution Strategies for DTx
Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.






Masterclass: Future EU Regulations for AI in Medical Devices
Are you trying to commercialize AI-based digital health solutions in the European Union (EU)? Would you like to learn practical steps on how to navigate the EU regulations for AI in medical devices? Join us in this masterclass led by Erik Vollebregt (Partner at Axon Lawyers) to deep dive into this topic.







Masterclass: Key Considerations for Inclusion on the Evernorth Digital Health Formulary
How do DTx products get listed on a formulary? And what happens next? Join this masterclass to hear from Mark Bini, the visionary who helped devise Evernorth's Digital Health Formulary.
.jpg)






Masterclass: Partnering with Health Systems in Digital Health
Are you working in digital health and looking for successful partnerships with health systems? Join this meeting to deep dive into this topic with other senior leaders in this field.







Driving Adoption for non-Prescription DTx
Without adoption, even the best DTx solution will have no impact. Apply now to join this meeting and discuss this topic further with your peers working in this space







DTx-Drug Combination Therapy: What Should the Trial Look Like?
DTx-Drug combinations can improve the treatment value, thus leading to better patient outcomes. Join HealthXL in this session to discuss this topic with thought leaders in this space.







Sprint: Pharma Sales Model for DTx-Drug Combination (Part 1)
While the combination of a drug with a DTx can increase the treatment value, there are many challenges when trying to fit these combinations into the pharma traditional sales model. Join this 2 part sprint to establish 5 key challenges and agree on 5 key recommendations to overcome them with your peers working in this space.







Sprint: Conditions Needed for Pharma to Launch Standalone DTx (Part 2)
Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part meeting to establish 5 key challenges and agree on 5 key recommendation to overcome them.







Masterclass: The New Reimbursement Pathway in France
The reimbursement path for digital health solutions in Europe has always been complex to navigate. Join this Masterclass led by Aymeric Perchant to deep dive into this topic.







Roadmap Execution in a Pharma-DTx Partnership
While the number of partnerships between DTx and Pharma have grown in the past years, we haven’t seen big successes yet, and part of that could be due to bad roadmap definition and its execution. Join your peers in this meeting to discuss this topic further







Innovation Showcase: Digital Health for Chronic Kidney Disease (CKD)
In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.







Building Incentive Models for Digital Health in Neurodegenerative Diseases
In Neurodegenerative Diseases, aging is a risk factor and as the older populations grow, its prevalence increases, leading to an enormous burden on healthcare systems. Join this meeting to deep dive into this topic with other senior leaders in this field.







Adoption Beyond Reimbursement for Digital Health in Oncology
Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join this meeting to deep dive into this topic with your peers working in this space.







HealthXL Webinar: Metaverse in Healthcare
Join us for our next HealthXL Webinar 'Metaverse in Healthcare' where we will take a deeper look at the potential the metaverse has in the healthcare space.







Integrating Oncology Digital Health with Health Systems Workflows
Oncology services have changed in recent years from the way cancer is diagnosed to how treatment is being delivered. Join other senior leaders in this session to deep dive into this topic.







Masterclass: Endpoints Selection in Clinical Trials for Digital Health Solutions
Proving clinical efficacy is one of the biggest challenges for SaMD manufacturers. However, it is key to getting buy-in from stakeholders. Join this Masterclass led by Shaheen Lakhan (Chief Medical Officer, Click Therapeutics) to depp dive into this topic with other senior leaders in this area.







Sprint: Conditions Needed for Pharma to Launch Standalone DTx (Part 1)
Unarguably, DTx solutions have clear benefits for patients. Join HealthXL in this 2 part Sprint where we will break this topic down into 5 key challenges and agre on 5 key recommendations to overcome the challenges.







Big Tech and Digital Health
There is no question that Big Tech has the capability to disrupt healthcare, though the complexity of healthcare ecosystems is not making it easy for these companies. Join this meeting to dive deeper into this topic and discuss how Big Tech is getting into digital health.







Building a Value Proposition that Addresses Payers Pain Points
Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. Join this meeting to deep dive into this topic with other senior leaders in this area.







How Can DTx Companies Monetize the RWD They Generate?
Real-World Data (RWD) can be highly valuable for many stakeholders in healthcare, such as pharma, MedTech, payers, or hospitals. Join this Masterclass, led by Philip Russmeyer (Founder, FITFILE) to discuss this topic further.







Digital Health for the Prediction of Cardiovascular Events
Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Join HealthXL in this meeting where we will focus on the use of digital health tools for the prediction of cardiovascular events.







Physician Adoption of Prescription DTx
Physician adoption is one of the keys to unlocking the revenues expected from DTx solutions. Join HealthXL in this meeting to discuss this topic with other senior leaders in this field.







Masterclass: Navigating the DiGA Framework: a Case Study
Regulatory clearance and the right commercialization model for a digital health product are key components of success in this rapidly growing space. Join us in this interactive masterclass led by Dr. Victor Stephani (responsible for Market Access and Chief of Staff at HelloBetter) to discuss this topic further.







Innovation showcase: Digital Biomarkers in Neurology
In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Biomarkers partners to discuss mutual challenges they face when building successful collaborations. Seats are limited so apply now to join this session.
.jpg)






Partnerships between Oncology Digital Health and Life Sciences Companies
In a complex disease area like oncology, treatments usually cause adverse effects that compromise patients' quality of life. Join this session to discuss this topic further with your peers working in this field.







Sprint: Integrating RPM into Health Systems and Hospital Workflows (Part 2)
While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join Part 2 of this sprint where we will continue this discussion and break this down into 5 key challenges and agree on 5 key recommendations to overcome them.







How to Sell DTx to Life Sciences Companies?
Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. Join HealthXL in this meeting to discuss this topic with thought leaders in this area.







Outcome Measures in Oncology Digital Health Interventions: What and How to Measure?
Digital health solutions can track a huge amount of data points, but tracking too many different measures can make you lose focus. Join HealthXL in this meeting to discuss this with other thought leaders working in this area.







Innovation Showcase: Digital Health Solutions for Decentralized Clinical Trials
In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this bilateral discussion.







The Drop in DTx Investments: What are the implications
When the pandemic was hitting the world, venture capitalists invested more than ever in Digital Therapeutics (DTx) as the world was moving away from the traditional in-person care settings, and patients needed new ways to access care and treatments. Join HealthXL to discuss this topic with your peers working in this area.







Success Metrics of Patient Engagement with DTx Solutions
In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers' expectations. Join other senior leaders in this session to discuss what the success metrics of patient engagement are for DTx solutions.







Masterclass: Clinical Trial Design Considerations for Prescription Digital Therapeutics and Therapeutic Digital Health Products
Are you considering clinical validation for a SaMD or SaMD/PDT+drug combination product? Join this meeting to discuss this topic further with others working in this field







Combined Label Claims for Drug + DTx Combinations
As more DTx-drug combinations emerge, regulation is becoming increasingly important. Join HealthXL in this meeting to dive deeper into this topic.







The Use of New Technologies to Improve Clinical Trial Operational Efficiency
Clinical trials are thoughtfully designed and implemented to ensure the right patients are involved, quality standards are strictly followed, and the endpoints selected are the right ones to show the drug’s safety and effectiveness. Join HealthXL in this discussion to dive deeper into this topic.







Partner Search and Selection for Digital Health Companies in Mental Health
Digital solutions have great potential in mental health, improving care access, symptom tracking, and treatment personalization. Join HealthXL in this meeting to discuss this topic further with your peers working in this area.







Sprint: Integrating RPM into Health Systems and Hospital Workflows (Part 1)
While integrating Remote Patient Monitoring programs (RPM) into health systems and hospital workflows is key to push the adoption rates, it is not an easy task. Join this two part session to discuss this topic further.







Adoption Beyond Reimbursement for Digital Health in Oncology
Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join HealthXL in this meeting to discuss this further.







Masterclass: The Essentials of Working with the FDA for the Approval of AI-based Solutions
Join this masterclass led by Tahir Rizvi (Head of Quality Assurance and Regulatory Affairs at Caption Health) and Armen Vidian (Digital Health Venture Capitalist) to learn more about the regulatory considerations for AI-based solutions in the US.







Masterclass: DTx Reimbursement in the US: Government-sponsored plans (Medicaid and Medicare)
Are you a digital therapeutics (DTx) company seeking reimbursement in the US market? Join this masterclass led by the biopharma and DTx reimbursement expert Mike Pace to dive deeper into this topic.







Masterclass: Investments in Digital Health: The Art of Storytelling
Are you a digital health company looking to fundraise, acquire new customers or hire key executives? If so, crafting a story that inspires, builds trust, and drives credibility is critical.







Executive 1-2-1 with the HealthXL Digital Health Community
Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!







HealthXL Webinar: The Unique Opportunities and Challenges of Digital Health in Rare Disease
In this webinar with Ankita Deshpande (Head of Innovation Accelerator at Alexion Pharmaceuticals), we will deep dive into the unique opportunities and challenges of digital health in rare diseases. Register now to secure your place!
.jpg)






What are the Best Business Models for DTx in the US?
What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss these questions and more!







Masterclass: Human-Centric Design for Digital Health Solutions
Healthcare is one of those areas that one would expect to be more human-centric, at the end of the day, what is more human than getting sick? Join HelathXL in this masterclass led by Kellee M. Franklin, PhD, Founder of Mindful Innovation Labs, and Carole Tremonti, VP Clinical Strategy at Project Cronin, where they will discuss how we can be more human-centric when creating digital health solutions for patients and the care team.







Are Pharma Partnerships the Wrong Strategy for DTx Companies?
While the digital therapeutics (DTx) market is increasingly growing, it is still small compared to large players in the healthcare industry such as pharma. Join HealthXL in this peer-to-peer discussion to deep dive into this topic.







What Will the Best Business Models Be for Virtual Care in Diabetes?
Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space.







Masterclass: Translating European Regulatory Guides into Practical Steps for DTx Solutions
Are you trying to commercialize a digital therapeutics (DTx) solution in the European Union (EU)? Would you like to learn practical steps on how to navigate the European regulatory landscape? Keep reading, this masterclass is for you!







Masterclass: The New Reimbursement Path for Digital Health in Belgium
The right commercialization model for a digital health product is a key component of success in this rapidly growing space. Join this masterclass led by Steven Vandeput, PhD, to discuss this topic further.







If DTx Companies Operated like Pharma, What Would We Have?
Pharma companies are huge corporations with complex operations to ensure the quality of their products and services. Join HealthXL in this meeting to deep dive into this topic with others working in this space.







Pharma Partnerships with Virtual Care Companies
The accelerated growth of the virtual care industry since the pandemic has opened many opportunities for virtual care companies. Join HealthXL in this meeting to dive deeper into this topic and discuss further with your peers working in this space.







Are DTx a Service or a Product?
Digital therapeutics (DTx) and drugs are very different care solutions. However, DTx are often compared to traditional pharmaceutical products because the terminology and definitions are unclear. Join this meeting to discuss this topic further with your peers.







Do’s and Don’ts when Seeking Partnerships for Digital Health in Oncology
Most digital health companies in oncology will struggle to get their products in the market on their own. Join HealthXL in this meeting to discuss the do's and don'ts when seeking partnerships for digital health companies in oncology.







Executive 1-2-1 with the HealthXL Digital Health Community
Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!







New Distribution Channels for DTx
Are you trying to figure out what is the best distribution channel for your digital therapeutics (DTx) solution? Join this meeting to discuss this topic further with your peers working in this space.







Sustainable Business Models for Digital Health in Neurology
Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Join this meeting to discuss this topic further with others working in this space.







HealthXL Webinar with Russell Glass: Business Models for Digital Companies in the Mental Health Space
What makes for a successful business model for digital companies in mental health? Join us in this fireside chat with Russell Glass, CEO at Headspace Health, where we will deep dive into the business models for digital companies in the mental health space. Register now to secure your place.







Evidence Requirements for DTx vs Drugs
Are you targeting payers as part of your market access strategy? What do you need to know about their evidence requirements for DTx? Join HealthXL in this meeting to discuss this topic further with your peers working in this space.







Seeking Capital for DTx
Are you a digital therapeutics (DTx) start-up seeking capital? How can companies get attention from investors in an increasingly competitive industry? Join HealthXL in this meeting to discuss this topic further with others working in this space.







DTx Evidence Generation: What can we learn from the Pharma and Medical Device Industries?
The definition of Digital Therapeutics (DTx) is broad, including many different solutions, making it hard to agree on the evidence generation standards. Join this meeting to dive deeper into this topic and learn from your peers working in this area.







Masterclass: Regulation of DTx in the US - Experience from a Real Company
Are you trying to get your DTx solution regulated in the US? Would you like to learn from the experiences of a real company? Join HealthXL in this masterclass led by Michelle Rubin-Onur from Blue Note Therapeutics to dive deeper into this topic







HealthXL Webinar with Julie Murchinson: Growth and Scalability Strategies in Digital Health
The investment case for digital health solutions is straightforward in many therapeutic areas, such as diabetes, oncology, mental health, women’s health, among others.
Join HealthXL's next webinar with Julie Murchinson, Partner at Transformation Capital, as we discuss growth and scalability strategies in digital health. Apply now to secure your place.
